Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source

被引:2
|
作者
Papapostolou, Stavroula [1 ,2 ]
Kearnsc, John [3 ]
Costello, Benedict T. [4 ,5 ]
O'Brien, Jessica [1 ,2 ]
Rudman, Murray [3 ]
Thompson, Mark C. [3 ]
Cloud, Geoffrey [6 ,7 ]
Stub, Dion [1 ,2 ]
Taylor, Andrew J. [1 ,2 ,4 ,8 ]
机构
[1] Alfred Hosp, Heart Ctr, Melbourne, Vic, Australia
[2] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia
[3] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic, Australia
[4] Baker Heart & Diabet Inst, Melbourne, Vic, Australia
[5] Western Hlth, Melbourne, Vic, Australia
[6] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia
[7] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia
[8] Alfred Hosp, Dept Cardiovasc Med, Melbourne, Vic, Australia
关键词
ESUS; Stroke; 4D flow CMR; Atrial myopathy/function; Cardiac magnetic resonance; RANDOMIZED-TRIAL RATIONALE; WAVE TERMINAL FORCE; TEMPORAL RELATIONSHIP; CRYPTOGENIC STROKE; FIBRILLATION; PREVENTION; STRAIN;
D O I
10.1016/j.ijcard.2023.131215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Left atrial myopathy has been implicated in atrial fibrillation (AF)-related stroke and embolic stroke of undetermined source (ESUS). Objective: To use advanced cardiac magnetic resonance (CMR) imaging techniques, including left atrial (LA) strain and 4D flow CMR, to identify atrial myopathy in patients with ESUS. Methods: 20 patients with ESUS and no AF or other cause for stroke, and 20 age and sex-matched controls underwent CMR with 4D flow analysis. Markers of LA myopathy were assessed including LA size, volume, ejection fraction, and strain. 4D flow CMR was performed to measure novel markers of LA stasis such as LA velocities and the LA residence time distribution time constant (RTDtc). These markers of LA myopathy were compared be-tween the two groups.Results: There was no significant difference in: CMR-calculated LA velocities or LA total, passive or active ejection fractions between the groups. There was no significant difference in CMR-derived reservoir, conduit or con-tractile average longitudinal strain between the ESUS and control groups (22.9 vs 22.6%, p=0.379, 11.2 +/- 3.5 vs 12.4 +/- 2.6% p=0.224, 10.8 +/- 3.2 vs 10.4 +/- 2.3%, p=0.625 respectively). Similarly, RTDtc was not significantly longer in ESUS patients compared to controls (1.3 +/- 0.2 vs 1.2 +/- 0.2, p=0.1).Conclusions: There were no significant differences in any CMR marker of atrial myopathy in ESUS patients compared to healthy controls, likely reflecting the multiple possible aetiologies of ESUS suggesting that the role LA myopathy plays in ESUS is smaller than previously thought.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] A Review of the Current Literature and Updates on Embolic Stroke of Undetermined Source (ESUS)
    Gogia, Bhanu
    Hasan, Saad
    Fisher, Marc
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2022, 24 (09) : 429 - 439
  • [42] Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source
    Hawkes, Maximiliano A.
    Farez, Mauricio F.
    Pertierra, Lucia
    Gomez-Schneider, Maia M.
    Pastor-Rueda, Jose M.
    Ameriso, Sebastian F.
    INTERNATIONAL JOURNAL OF STROKE, 2018, 13 (02) : 190 - 194
  • [43] Left atrial function index in embolic stroke of undetermined source: A case-control study
    Tajmirriahi, Marzieh
    Salari, Parisa
    Saadatnia, Mohammad
    NEUROLOGY ASIA, 2022, 27 (02) : 275 - 279
  • [44] Factors associated with the detection of atrial fibrillation in patients with embolic stroke of undetermined source
    Bae, Jae-Han
    Ryu, Jae-Chan
    Ha, Sang Hee
    Cho, Min Soo
    Cha, Myung-Jin
    Chang, Jun Young
    Kang, Dong-Wha
    Kwon, Sun U.
    Kim, Jong S.
    Kim, Bum Joon
    BMC NEUROLOGY, 2025, 25 (01)
  • [45] Impact of Left Atrial Appendage Morphology on Recurrence in Embolic Stroke of Undetermined Source and Atrial Cardiopathy
    Gwak, Dong-Seok
    Choi, WooChan
    Kim, Yong-Won
    Kim, Yong-Sun
    Hwang, Yang-Ha
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [46] Long-Term Cardiac Monitoring After Embolic Stroke of Undetermined Source: Search Longer, Look Harder
    Sagris, Dimitrios
    Harrison, Stephanie L.
    Buckley, Benjamin J. R.
    Ntaios, George
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (09) : E311 - E317
  • [47] Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors
    Verma, Nishant
    Ziegler, Paul D.
    Liu, Shufeng
    Passman, Rod S.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (02) : 146 - 153
  • [48] Atrial CARdiac Magnetic resonance imaging in patients with embolic stroke of unknown source without documented Atrial Fibrillation (CARM-AF): Study design and clinical protocol
    Kotadia, Irum D.
    O'Dowling, Robert
    Aboagye, Akosua
    Sim, Iain
    O'Hare, Daniel
    Lemus-Solis, Jose-Alonso
    Roney, Caroline H.
    Dweck, Marc
    Chiribiri, Amedeo
    Plein, Sven
    Sztriha, Laszlo
    Scott, Paul
    Harrison, James
    Ramsay, Deborah
    Birns, Jonathan
    Somerville, Peter
    Bhalla, Ajay
    Niederer, Steven
    O'Neill, Mark
    Williams, Steven E.
    HEART RHYTHM O2, 2022, 3 (02): : 196 - 203
  • [49] Risk Stratification Tools to Guide a Personalized Approach for Cardiac Monitoring in Embolic Stroke of Undetermined Source
    Louka, Anna Maria
    Nagraj, Sanjana
    Adamou, Anastasia T.
    Perlepe, Kalliopi
    Godefroy, Olivier
    Bugnicourt, Jean-Marc
    Palaiodimos, Leonidas
    Ntaios, George
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (18):
  • [50] Value of HAVOC and Brown ESUS-AF scores for atrial fibrillation on implantable cardiac monitors after embolic stroke of undetermined source
    Grygorowicz, Claire
    Benali, Karim
    Serzian, Guillaume
    Mouhat, Basile
    Duloquin, Gauthier
    Pommier, Thibaut
    Didier, Romain
    Laurent, Gabriel
    Bejot, Yannick
    Maille, Baptiste
    Vuillier, Fabrice
    Badoz, Marc
    Guenancia, Charles
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (01)